The shareholders of Galápagos NV have approved the appointment of Ronald Brus to the company’s board of directors. Dr Brus, who is president and chief executive of Crucell NV, previously served on the Galápagos board from 2000 until the company’s initial public offering in May 2005. Dr Brus holds a medical degree from the University of Groningen in the Netherlands. Before joining Crucell, he was a product planning physician at Forest Laboratories Inc and a medical director at Zambon BV. Copyright 2010 Evernow Publishing Ltd